Marksans-Pharma Stock/Share Prices, Buy and Sell Marksans-Pharma BSE Stocks

Marksans Pharma Ltd NSE / BSE
Pharmaceuticals, Mid Cap

Invest

13 Dec 2018 | 03:59 PM

28.15

-0.20 (-0.71%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-20.37%

Return (1Y)

Underperformed S&P BSE Healthcare by 20.12%
More Volatile

3.21%

Standard Deviation (1Y)

Higher than S&P BSE Healthcare by 2.07%
Not so consistent

5/12

Months

underperformed S&P BSE Healthcare
AxisDirect View

No View

52 Week High-Low

News & Announcements

Marksans Pharma consolidated net profit rises 97.60% in the September 2018 quarter
29 days ago

Marksans Pharma consolidated net profit rises 97.60% in the September 2018 quarter

14 - Nov - 2018 12:00 AM | 29 days ago

Net profit of Marksans Pharma rose 97.60% to Rs 20.57 crore in the quarter ended September 2018 as against Rs 10.41 crore during the previous quarter ended September 2017. Sales declined 1.74% to Rs 269.04 crore in the quarter ended September 2018 as against Rs 273.81 crore during the previous quarter ended September 2017.
Particulars Quarter Ended
Sep. 2018 Sep. 2017 % Var.
Sales 269.04 273.81 -2
OPM % 13.80 8.98 -
PBDT 33.26 21.55 54
PBT 27.72 14.57 90
NP 20.57 10.41 98
Powered by Capital Market - Live News
Marksans Pharma to conduct board meeting
35 days ago

Marksans Pharma to conduct board meeting

08 - Nov - 2018 12:00 AM | 35 days ago

Marksans Pharma will hold a meeting of the Board of Directors of the Company on 13 November 2018.
Powered by Capital Market - Live News
Marksans Pharma schedules AGM
101 days ago

Marksans Pharma schedules AGM

03 - Sep - 2018 12:00 AM | 101 days ago

Marksans Pharma announced that the Annual General Meeting (AGM) of the company will be held on 27 September 2018.
Powered by Capital Market - Live News
Marksans Pharma standalone net profit rises 1095.69% in the June 2018 quarter
129 days ago

Marksans Pharma standalone net profit rises 1095.69% in the June 2018 quarter

06 - Aug - 2018 12:00 AM | 129 days ago

Net profit of Marksans Pharma rose 1095.69% to Rs 13.87 crore in the quarter ended June 2018 as against Rs 1.16 crore during the previous quarter ended June 2017. Sales rose 77.78% to Rs 93.14 crore in the quarter ended June 2018 as against Rs 52.39 crore during the previous quarter ended June 2017.
Particulars Quarter Ended
Jun. 2018 Jun. 2017 % Var.
Sales 93.14 52.39 78
OPM % 18.34 14.96 -
PBDT 18.80 6.56 187
PBT 16.68 2.75 507
NP 13.87 1.16 1096
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Marksans Pharma Ltd has decreased by -30.48% since past 3 Months
FII shareholding in Marksans Pharma Ltd has decreased by -61% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2018	Sep. 2017	% Var.
Sales	269.04	273.81	-2
OPM %	13.80	8.98	-
PBDT	33.26	21.55	54
PBT	27.72	14.57	90
NP	20.57	10.41	98

Particulars	Quarter Ended
	Jun. 2018	Jun. 2017	% Var.
Sales	93.14	52.39	78
OPM %	18.34	14.96	-
PBDT	18.80	6.56	187
PBT	16.68	2.75	507
NP	13.87	1.16	1096

General Notifications

My Notifications

Research Notifications

Marksans Pharma Ltd NSE / BSE Pharmaceuticals, Mid Cap

28.15 -0.20 (-0.71%)

News & Announcements

Price vs Volume

Stock Trivia

Marksans Pharma Ltd NSE / BSE
Pharmaceuticals, Mid Cap

28.15

-0.20 (-0.71%)